☰

Jennifer A. Sinnott, Ph.D. - Publications

Affiliations: 
2012 Biostatistics Harvard University, Cambridge, MA, United States 
Area:
Biostatistics Biology
Tree Info Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Swami U, Sinnott JA, Haaland B, Sayegh N, McFarland TR, Tripathi N, Maughan BL, Rathi N, Sirohi D, Nussenzveig R, Kohli M, Pal SK, Agarwal N. Treatment Pattern and Outcomes with Systemic Therapy in Men with Metastatic Prostate Cancer in the Real-World Patients in the United States. Cancers. 13. PMID 34638435 DOI: 10.3390/cancers13194951  0.307
2020 Barrington DA, Sinnott JA, Calo C, Cohn DE, Cosgrove CM, Felix AS. Where you live matters: A National Cancer Database study of Medicaid expansion and endometrial cancer outcomes. Gynecologic Oncology. PMID 32527568 DOI: 10.1016/J.Ygyno.2020.05.018  0.398
2018 Ahearn TU, Peisch S, Pettersson A, Ebot EM, Zhou K, Graff RE, Sinnott JA, Fazli L, Judson GL, Bismar TA, Rider JR, Gerke T, Chan JM, Fiorentino M, Flavin R, et al. Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease. Carcinogenesis. PMID 30165429 DOI: 10.1093/Carcin/Bgy112  0.504
2018 Sinnott JA, Brumberg K, Wilson KM, Ebot EM, Giovannucci EL, Mucci LA, Rider JR. Differential Gene Expression in Prostate Tissue According to Ejaculation Frequency. European Urology. PMID 29784192 DOI: 10.1016/J.Eururo.2018.05.006  0.498
2018 Felix AS, Sinnott JA, Vetter MH, Rhoades J, Cohn DE, Backes FJ, Sherman ME, Suarez AA. Detection of endometrial cancer cells in the fallopian tube lumen is associated with adverse prognostic factors and reduced survival. Gynecologic Oncology. PMID 29754740 DOI: 10.1016/J.Ygyno.2018.05.005  0.379
2018 Sinnott JA, Cai T. Pathway aggregation for survival prediction via multiple kernel learning. Statistics in Medicine. PMID 29664143 DOI: 10.1002/Sim.7681  0.506
2018 Gerke T, Tyekucheva S, Creed JH, Penney KL, Sinnott JA, Ebot E, Berglund AE, Loda M, Stampfer MJ, Kraft P, Parmigiani G, Mucci LA. Abstract A045: All happy families are alike: Transcriptomic homogeneity in indolent prostate tumors is a useful prognostic biomarker Cancer Research. 78. DOI: 10.1158/1538-7445.Prca2017-A045  0.548
2018 Felix A, Sinnott J, Rhoades J, Cohn D, Backes F, Sherman M, Suarez A. Intraluminal tumor cells are associated with adverse prognostic factors and survival among women with endometrial cancer Gynecologic Oncology. 149: 167. DOI: 10.1016/J.Ygyno.2018.04.382  0.369
2017 Shisler R, Sinnott JA, Wang V, Hebert C, Salani R, Felix AS. Life after endometrial cancer: A systematic review of patient-reported outcomes. Gynecologic Oncology. PMID 29150143 DOI: 10.1016/J.Ygyno.2017.11.007  0.333
2017 Ebot EM, Gerke T, Labbé DP, Sinnott JA, Zadra G, Rider JR, Tyekucheva S, Wilson KM, Kelly RS, Shui IM, Loda M, Kantoff PW, Finn S, Vander Heiden MG, Brown M, et al. Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer. Cancer. PMID 28700821 DOI: 10.1002/Cncr.30831  0.497
2016 Kelly RS, Sinnott JA, Rider JR, Ebot EM, Gerke T, Bowden M, Pettersson A, Loda M, Sesso HD, Kantoff PW, Martin NE, Giovannucci EL, Tyekucheva S, Heiden MV, Mucci LA. The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study. Cancer & Metabolism. 4: 22. PMID 27980733 DOI: 10.1186/S40170-016-0161-9  0.452
2016 Sinnott JA, Peisch S, Tyekucheva S, Gerke TA, Lis RT, Rider JR, Fiorentino M, Stampfer MJ, Mucci LA, Loda M, Penney KL. Prognostic Utility of a New mRNA Expression Signature of Gleason Score. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27663590 DOI: 10.1158/1078-0432.Ccr-16-1245  0.447
2016 Stopsack KH, Gerke TA, Sinnott JA, Penney KL, Tyekucheva S, Sesso HD, Andersson SO, Andrén O, Cerhan JR, Giovannucci EL, Mucci LA, Rider JR. Cholesterol metabolism and prostate cancer lethality. Cancer Research. PMID 27325648 DOI: 10.1158/0008-5472.Can-16-0903  0.546
2016 Neykov M, Hejblum BP, Sinnott JA. Kernel machine score test for pathway analysis in the presence of semi-competing risks. Statistical Methods in Medical Research. PMID 27255336 DOI: 10.1177/0962280216653427  0.398
2016 Rider JR, Wilson KM, Sinnott JA, Kelly RS, Mucci LA, Giovannucci EL. Reply to Herney Andrés García-Perdomo and Ramiro Manzano Nunez's Letter to the Editor Re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer M. Sinnott, Rachel S. Kelly, Lorelei A. Mucci, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.03.027: Looking Deeper: P-hacking and Some Other Bias. European Urology. PMID 27156131 DOI: 10.1016/J.Eururo.2016.04.032  0.364
2016 Sinnott JA, Cai T. Inference for survival prediction under the regularized Cox model. Biostatistics (Oxford, England). PMID 27107008 DOI: 10.1093/Biostatistics/Kxw016  0.46
2016 Rider JR, Wilson KM, Sinnott JA, Kelly RS, Mucci LA, Giovannucci EL. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. European Urology. PMID 27033442 DOI: 10.1016/J.Eururo.2016.03.027  0.458
2016 Wilson KM, Gerke T, Ebot E, Sinnott JA, Rider JR, Mucci LA. Differential gene expression in prostate tissue according to vasectomy. Journal of Clinical Oncology. 34: 298-298. DOI: 10.1200/Jco.2016.34.2_Suppl.298  0.525
2016 Rider JR, Sinnott JA, Mucci LA. Gene expression in prostate tissue according to frequency of ejaculation. Journal of Clinical Oncology. 34: 25-25. DOI: 10.1200/Jco.2016.34.2_Suppl.25  0.447
2016 Kelly RS, Sinnott JA, Rider JR, Ebot E, Gerke T, Penney KL, Bowden M, Pettersson A, Loda M, Stampfer M, Kantoff P, Martin NE, Giovannucci EL, Tyekucheva S, Heiden MV, et al. Abstract A25: Tumor metabolism as a driver of lethal prostate cancer Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-A25  0.531
2016 Rider J, Wilson K, Gerke T, Ebot E, Sinnott J, Mucci L. MP04-17 DIFFERENTIAL GENE EXPRESSION IN PROSTATE TISSUE ACCORDING TO SEXUAL BEHAVIORS Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.1952  0.387
2015 Lu D, Sinnott JA, Valdimarsdottir UA, Fang F, Gerke T, Tyekucheva S, Fiorentino M, Lambe M, Sesso HD, Sweeney CJ, Wilson KM, Giovannucci EL, Loda M, Mucci LA, Fall K. Stress-Related Signaling Pathways in Lethal and Non-Lethal Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26490316 DOI: 10.1158/1078-0432.Ccr-15-0101  0.481
2015 Martin NE, Gerke T, Sinnott JA, Stack EC, Andren O, Andersson SO, Johansson JE, Fiorentino M, Finn S, Fedele G, Stampfer M, Kantoff PW, Mucci LA, Loda M. Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer. Molecular Cancer Research : McR. PMID 26124442 DOI: 10.1158/1541-7786.Mcr-14-0569  0.448
2015 Sinnott JA, Rider JR, Carlsson J, Gerke T, Tyekucheva S, Penney KL, Sesso HD, Loda M, Fall K, Stampfer MJ, Mucci LA, Pawitan Y, Andersson SO, Andrén O. Molecular differences in transition zone and peripheral zone prostate tumors. Carcinogenesis. 36: 632-8. PMID 25870172 DOI: 10.1093/Carcin/Bgv051  0.433
2015 Rider JR, Fiorentino M, Kelly R, Gerke T, Jordahl K, Sinnott JA, Giovannucci EL, Loda M, Mucci LA, Finn S. Tumor expression of adiponectin receptor 2 and lethal prostate cancer. Carcinogenesis. 36: 639-47. PMID 25863129 DOI: 10.1093/Carcin/Bgv048  0.535
2015 Penney KL, Sinnott JA, Tyekucheva S, Gerke T, Shui IM, Kraft P, Sesso HD, Freedman ML, Loda M, Mucci LA, Stampfer MJ. Association of prostate cancer risk variants with gene expression in normal and tumor tissue. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 255-60. PMID 25371445 DOI: 10.1158/1055-9965.Epi-14-0694-T  0.521
2015 Stopsack KH, Sinnott JA, Cerhan JR, Mucci LA, Rider JR. Cholesterol metabolism and prostate cancer-specific mortality. Journal of Clinical Oncology. 33: 12-12. DOI: 10.1200/Jco.2015.33.7_Suppl.12  0.517
2015 Kelly RS, Sinnott JA, Rider JR, Ebot E, Gerke T, Penney K, Bowden M, Loda M, Kantoff PW, Martin NE, Giovannucci EL, Pettersson AP, Tyekucheva S, Wilson KM, Heiden MV, et al. Abstract 5168: Tumor metabolism as a driver of lethal prostate cancer Cancer Research. 75: 5168-5168. DOI: 10.1158/1538-7445.Am2015-5168  0.49
2014 Sinnott JA, Dai W, Liao KP, Shaw SY, Ananthakrishnan AN, Gainer VS, Karlson EW, Churchill S, Szolovits P, Murphy S, Kohane I, Plenge R, Cai T. Improving the power of genetic association tests with imperfect phenotype derived from electronic medical records. Human Genetics. 133: 1369-82. PMID 25062868 DOI: 10.1007/S00439-014-1466-9  0.45
2014 Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, Judson GL, Lis R, Bailey D, Fiore C, Nuttall E, Martin NE, Stack E, Penney KL, Rider JR, ... Sinnott J, et al. SPINK1 protein expression and prostate cancer progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4904-11. PMID 24687926 DOI: 10.1158/1078-0432.Ccr-13-1341  0.517
2013 Sinnott JA, Cai T. Omnibus risk assessment via accelerated failure time kernel machine modeling. Biometrics. 69: 861-73. PMID 24328713 DOI: 10.1111/Biom.12098  0.49
2013 Zu K, Martin NE, Fiorentino M, Flavin R, Lis RT, Sinnott JA, Finn S, Penney KL, Ma J, Fazli L, Gleave ME, Bismar TA, Stampfer MJ, Pollak MN, Loda M, et al. Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1984-93. PMID 23983239 DOI: 10.1158/1055-9965.Epi-13-0349  0.486
2013 Penney KL, Stampfer MJ, Jahn JL, Sinnott JA, Flavin R, Rider JR, Finn S, Giovannucci E, Sesso HD, Loda M, Mucci LA, Fiorentino M. Gleason grade progression is uncommon. Cancer Research. 73: 5163-8. PMID 23946472 DOI: 10.1158/0008-5472.Can-13-0427  0.454
2012 Wang S, Wu J, Suburu J, Gu Z, Cai J, Axanova LS, Cramer SD, Thomas MJ, Perry DL, Edwards IJ, Mucci LA, Sinnott JA, Loda MF, Sui G, Berquin IM, et al. Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer. Carcinogenesis. 33: 404-12. PMID 22159221 DOI: 10.1093/Carcin/Bgr290  0.479
2011 Penney KL, Sinnott JA, Fall K, Pawitan Y, Hoshida Y, Kraft P, Stark JR, Fiorentino M, Perner S, Finn S, Calza S, Flavin R, Freedman ML, Setlur S, Sesso HD, et al. mRNA expression signature of Gleason grade predicts lethal prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2391-6. PMID 21537050 DOI: 10.1200/Jco.2010.32.6421  0.518
2010 Penney KL, Pyne S, Schumacher FR, Sinnott JA, Mucci LA, Kraft PL, Ma J, Oh WK, Kurth T, Kantoff PW, Giovannucci EL, Stampfer MJ, Hunter DJ, Freedman ML. Genome-wide association study of prostate cancer mortality. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2869-76. PMID 20978177 DOI: 10.1158/1055-9965.Epi-10-0601  0.51
2010 Fiorentino M, Judson G, Penney K, Flavin R, Stark J, Fiore C, Fall K, Martin N, Ma J, Sinnott J, Giovannucci E, Stampfer M, Sesso HD, Kantoff PW, Finn S, et al. Immunohistochemical expression of BRCA1 and lethal prostate cancer. Cancer Research. 70: 3136-9. PMID 20388772 DOI: 10.1158/0008-5472.Can-09-4100  0.505
2009 Stark JR, Wiklund F, Grönberg H, Schumacher F, Sinnott JA, Stampfer MJ, Mucci LA, Kraft P. Toll-like receptor signaling pathway variants and prostate cancer mortality. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1859-63. PMID 19505919 DOI: 10.1158/1055-9965.Epi-08-0981  0.423
2009 Stark JR, Perner S, Stampfer MJ, Sinnott JA, Finn S, Eisenstein AS, Ma J, Fiorentino M, Kurth T, Loda M, Giovannucci EL, Rubin MA, Mucci LA. Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3459-64. PMID 19433685 DOI: 10.1200/Jco.2008.20.4669  0.517
2008 Judson G, Sinnott J, Stark J, Penny K, Stampfer M, Hunter D, Loda M, Fiorentino M, Finn S, Schumacher F, Giovannucci E, Mucci L. Abstract A76: Nuclear androgen receptor expression is linked to two SNPs in prostate tumor tissue Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-A76  0.437
Show low-probability matches.